You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

bevacizumab (Avastin)

Showing 1 - 25 of 2,437
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Multiforme Trial in Philadelphia (Bevacizumab)

Recruiting
  • Glioblastoma Multiforme
  • Philadelphia, Pennsylvania
    (unnamed)
Aug 8, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab)

Recruiting
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • New York, New York
    Lenox Hill Brain Tumor Center
Nov 10, 2022

Glioblastoma Multiforme, Brain Tumor Trial in New York (Bevacizumab)

Active, not recruiting
  • Glioblastoma Multiforme
  • Brain Tumor
  • New York, New York
    Lenox Hill Brain Tumor Center
Jun 20, 2022

Breast Cancer Trial in Oslo, Trondheim (Aromatase Inhibitor, Bevacizumab, Epirubicine)

Completed
  • Breast Cancer
  • Aromatase Inhibitor
  • +6 more
  • Oslo, Norway
  • +2 more
Jan 5, 2023

Vestibular Schwannoma Trial in New York (Bevacizumab (Avastin))

Suspended
  • Vestibular Schwannoma
  • Bevacizumab (Avastin)
  • New York, New York
    Lenox Hill Brain Tumor Center
Oct 27, 2021

Glioblastoma, Glioblastoma Multiforme, Glioma, Malignant Trial in New York (Repeated Superselective Intraarterial Cerebral

Recruiting
  • Glioblastoma
  • +6 more
  • Repeated Superselective Intraarterial Cerebral infusion (SIACI) of Bevacizumab (Avastin) with Temozolomide and Radiation
  • Temozolomide and Radiation Alone
  • New York, New York
    Lenox Hill Brain Tumor Center
May 5, 2022

Glioblastoma, Optic Neuropathy Trial (Bevacizumab (Avastin))

Withdrawn
  • Glioblastoma
  • Optic Neuropathy
  • Bevacizumab (Avastin)
  • (no location specified)
Nov 29, 2021

89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

Recruiting
  • Neurofibromatosis 2
  • Bevacizumab Zirconium Zr-89
  • Leiden, Zuid-Holland, Netherlands
    Leiden University Medical Center
Jan 5, 2023

Healthy Volunteers Trial in Auckland, Christchurch (HD204, Avastin)

Completed
  • Healthy Volunteers
  • Auckland, New Zealand
  • +1 more
Aug 27, 2021

Predictive Factors and Biological Imaging of Response to

Completed
  • Metastatic
  • Breast Cancer
  • Bordeaux, France
  • +18 more
Jan 25, 2023

Rectal Cancer, Lung Cancer, Ovarian Cancer Trial in Changchun (Bevacizumab injection, Bevacizumab injection(Avastin))

Completed
  • Rectal Cancer
  • +4 more
  • Bevacizumab injection
  • Bevacizumab injection（Avastin）
  • Changchun, Jilin, China
    Affiliated Hospital of Changchun University of Traditional Chine
Jul 25, 2022

Colorectal Cancer, Peritoneal Metastases Trial in Eindhoven, Rotterdam (Irinotecan, FOLFOX regimen, Bevacizumab)

Recruiting
  • Colorectal Cancer
  • Peritoneal Metastases
  • Eindhoven, Netherlands
  • +1 more
Aug 15, 2023

Recurrent Glioblastoma Trial in Miami (Intensity Modulated Proton Therapy (IMPT), Bevacizumab)

Recruiting
  • Recurrent Glioblastoma
  • Miami, Florida
    University of Miami
Sep 30, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma, Fibrillary Astrocytomas Trial in Miami (SIACI of cetuximab and bevacizumab)

Not yet recruiting
  • Glioblastoma Multiforme
  • +4 more
  • SIACI of cetuximab and bevacizumab
  • Miami, Florida
    Jackson Memorial Hospital
Jul 14, 2023

Glioblastoma Trial (Bevacizumab, PD-L1 t-haNK, N-803)

Not yet recruiting
  • Glioblastoma
  • (no location specified)
Sep 25, 2023

NSCLC Trial in Russian Federation (Bevacizumab, Paclitaxel, Carboplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Arkhangel'sk, Russian Federation
  • +10 more
Dec 8, 2022

Fruquintinib With PD-1 Inhibitors Versus TAS-102 With

Completed
  • Metastatic Colorectal Adenocarcinoma
  • Changsha, Hunan, China
    Hunan Cancer hospital
Sep 2, 2023

Hepatocellular Carcinoma (HCC) Trial (Durvalumab, Bevacizumab, Transarterial Radioembolization (TARE))

Not yet recruiting
  • Hepatocellular Carcinoma (HCC)
  • (no location specified)
Sep 11, 2023

Trifluridine/Tipiracil Plus Bevacizumab Versus

Completed
  • Metastatic Colorectal Adenocarcinoma
  • Changsha, Hunan, China
    Hunan Cancer hospital
May 11, 2023

Healthy Trial in Hangzhou (SCT510, Bevacizumab)

Completed
  • Healthy
  • Hangzhou, Zhejiang, China
    First Affiliated Hospital of Zhejiang University
Nov 8, 2021

Hepatocellular Carcinoma Trial (Atezolizumab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Oct 18, 2023

Carcinoma, Hepatocellular Trial (Atezolizumab, Bevacizumab, Tiragolumab)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • (no location specified)
Jun 14, 2023

Metastatic Breast Cancer, Advanced Breast Cancer, Triple Negative Breast Cancer Trial in Worldwide (Atezolizumab)

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Paris, France
  • +24 more
Jun 7, 2022

Healthy Trial in Zuidlaren (MYL-1402O, US marketed Avastin(R), EU marketed Avastin(R))

Completed
  • Healthy
  • Zuidlaren, Netherlands
    PRA Health Sciences - Early Development Services
Mar 9, 2022

Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial (Atezolizumab Injection, Bevacizumab, Transarterial

Not yet recruiting
  • Hepatocellular Carcinoma
  • BCLC Stage B Hepatocellular Carcinoma
  • Atezolizumab Injection
  • +2 more
  • (no location specified)
Mar 16, 2023